✦ LIBER ✦

Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C

✍ Scribed by Junji Kato; Koji Miyanishi; Masayoshi Kobune; Tokiko Nakamura; Kohichi Takada; Rishu Takimoto; Yutaka Kawano; Sho Takahashi; Minoru Takahashi; Yasushi Sato; Tetsuji Takayama; Yoshiro Niitsu

Book ID: 106180216
Publisher: Springer Japan
Year: 2007
Tongue: English
Weight: 147 KB
Volume: 42
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-007-2095-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

117 SEROMARKERS FOR LONG-TERM PREDICTION

117 SEROMARKERS FOR LONG-TERM PREDICTION OF HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH CHRONIC HEPATITIS C

✍ M.-H. Lee; H.-I. Yang; S.-N. Lu; C.-L. Jen; S.-H. Yeh; C.-J. Liu; P.-J. Chen; S. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Sa1060 Long-Term Assessment of Hepatocel

Sa1060 Long-Term Assessment of Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients With Sustained Viral Response to Antiviral Therapy

✍ Wang, Chun-Hsiang; Chang, Kuo-Kwen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Hepatic iron accumulation is an independ

Hepatic iron accumulation is an independent risk factor for the development of hepatocellular carcinoma after interferon therapy in patients with chronic hepatitis C

✍ Namiki Izumi; Yasuhiro Asahina; Masakatsu Uchihara; Noguchi Osamu; Nobuhiko Kana 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 193 KB

484 IMPACT OF LIVER FIBROSIS IN DEVELOPM

484 IMPACT OF LIVER FIBROSIS IN DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS TREATED WITH ANTIVIRAL THERAPY: LONG TERM FOLLOW UP STUDY

✍ Pellicelli, A.M.; Vignally, P.; Romano, M.; Miglioresi, L.; Mazzoni, E.; Mecenat 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 71 KB

408 RISK FACTORS FOR DEVELOPMENT OF HEPA

408 RISK FACTORS FOR DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS C AFTER SUSTAINED RESPONSE TO PEGINTERFERON AND RIBAVIRIN COMBINATION THERAPY

✍ K.-C. Chang; T.-H. Hu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Risk factors for the development of hepa

Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy

✍ HAJIME TOKITA; HIDEO FUKUI; AKIHISA TANAKA; HIROSHI KAMITSUKASA; MICHIYASU YAGUR 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB